These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16809632)

  • 21. Factors predicting non-completion of tuberculosis treatment among HIV-infected patients in Barcelona (1987-1996).
    Tangüis HG; Caylà JA; García de Olalla PG; Jansà JM; Brugal MT
    Int J Tuberc Lung Dis; 2000 Jan; 4(1):55-60. PubMed ID: 10654645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seven-year retrospective study understanding the latent TB infection treatment cascade of care among adults in a low incidence country.
    Sullivan K; Pease C; Zwerling A; Mallick R; Van Dyk D; Mulpuru S; Allen C; Alsdurf H; Alvarez GG
    BMC Public Health; 2021 May; 21(1):964. PubMed ID: 34020616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Completion of treatment for latent tuberculosis infection with monthly drug dispensation directly through the tuberculosis clinic.
    Dobler CC; Marks GB
    PLoS One; 2012; 7(11):e48900. PubMed ID: 23139824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control.
    Cohn DL
    Clin Infect Dis; 2000 Jul; 31(1):120-4. PubMed ID: 10913407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
    Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
    J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders - A retrospective cohort study in Taiwan.
    Huang SF; Chen MH; Wang FD; Tsai CY; Fung CP; Su WJ
    J Microbiol Immunol Infect; 2018 Dec; 51(6):784-793. PubMed ID: 28739436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical trial of a financial incentive to go to the tuberculosis clinic for isoniazid after release from jail.
    White MC; Tulsky JP; Reilly P; McIntosh HW; Hoynes TM; Goldenson J
    Int J Tuberc Lung Dis; 1998 Jun; 2(6):506-12. PubMed ID: 9626609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The scope and impact of treatment of latent tuberculosis infection in the United States and Canada.
    Sterling TR; Bethel J; Goldberg S; Weinfurter P; Yun L; Horsburgh CR;
    Am J Respir Crit Care Med; 2006 Apr; 173(8):927-31. PubMed ID: 16424442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Latent tuberculous infection in the United States and Canada: who completes treatment and why?
    Hirsch-Moverman Y; Shrestha-Kuwahara R; Bethel J; Blumberg HM; Venkatappa TK; Horsburgh CR; Colson PW;
    Int J Tuberc Lung Dis; 2015 Jan; 19(1):31-8. PubMed ID: 25519787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In closely monitored patients, adherence in the first month predicts completion of therapy for latent tuberculosis infection.
    Menzies D; Dion MJ; Francis D; Parisien I; Rocher I; Mannix S; Schwartzman K
    Int J Tuberc Lung Dis; 2005 Dec; 9(12):1343-8. PubMed ID: 16466056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient choice promotes adherence in preventive treatment for latent tuberculosis.
    Rennie TW; Bothamley GH; Engova D; Bates IP
    Eur Respir J; 2007 Oct; 30(4):728-35. PubMed ID: 17626113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000.
    Bennett DE; Courval JM; Onorato I; Agerton T; Gibson JD; Lambert L; McQuillan GM; Lewis B; Navin TR; Castro KG
    Am J Respir Crit Care Med; 2008 Feb; 177(3):348-55. PubMed ID: 17989346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of tuberculosis in screened subjects without known risk factors for active disease.
    Cook VJ; Hernández-Garduño E; Elwood RK
    Int J Tuberc Lung Dis; 2008 Aug; 12(8):903-8. PubMed ID: 18647449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Missed opportunities for tuberculosis prevention in New York City, 2003.
    Slopen ME; Laraque F; Piatek AS; Ahuja SD
    J Public Health Manag Pract; 2011; 17(5):421-6. PubMed ID: 21788779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving tuberculosis therapy completion after jail: translation of research to practice.
    White MC; Tulsky JP; Menendez E; Arai S; Goldenson J; Kawamura LM
    Health Educ Res; 2005 Apr; 20(2):163-74. PubMed ID: 15314035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States.
    LoBue PA; Enarson DA; Thoen TC
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1226-32. PubMed ID: 20843412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment adherence of the latently infected tuberculosis population (post-Katrina) at Wetmore TB Clinic, New Orleans, USA.
    Bieberly J; Ali J
    Int J Tuberc Lung Dis; 2008 Oct; 12(10):1134-8. PubMed ID: 18812042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost of nurse-managed latent tuberculous infection treatment among hard-to-reach immigrants in Israel.
    Bishara H; Ore L; Vinitsky O; Bshara H; Armaly N; Weiler-Ravell D
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):799-804. PubMed ID: 26056104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No evidence for multiple-drug prophylaxis for tuberculosis compared with isoniazid alone in Southeast Asian refugees and migrants: completion and compliance are major determinants of effectiveness.
    MacIntyre CR; Ansari MZ; Carnie J; Hart WG
    Prev Med; 2000 May; 30(5):425-32. PubMed ID: 10845752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors Associated With Latent Tuberculosis Infection Treatment Failure Among Patients With Commercial Health Insurance-United States, 2005-2016.
    Iqbal SA; Isenhour CJ; Mazurek G; Langer AJ; Chang MH; Truman BI
    J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):E151-E161. PubMed ID: 31688742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.